RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2012-04-30

Last Posted Date: 2013-11-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 24

Registration Number: NCT01587690

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

High Dose Vitamin C in the Critically Ill Patient

Phase 2

Terminated

Conditions: Shock

Interventions: Other: Ringers Lactate or Normal Saline
Drug: Ascorbic Acid

First Posted Date: 2012-04-30

Last Posted Date: 2017-05-11

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 11

Registration Number: NCT01587963

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Effect of Gabapentin on Orthopedic Pain

Phase 4

Terminated

Conditions: Degenerative Arthritis and Postoperative Pain

Interventions: Drug: Placebo
Drug: Gapabentin

First Posted Date: 2012-03-07

Last Posted Date: 2021-01-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 34

Registration Number: NCT01546857

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

Use of Transesophageal Echocardiography to Measure Intraoperative Renal Resistive Index and Predict Acute Renal Injury

Terminated

Conditions: Subjects Undergoing Cardiac or Major Surgery Where TEE is Used as a Matter of Routine

First Posted Date: 2012-03-07

Last Posted Date: 2015-04-24

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 13

Registration Number: NCT01547065

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

MRI-Guided Laser Induced Thermal Therapy

Terminated

Conditions: Malignant Glioma

Interventions: Procedure: laser interstitial thermal therapy

First Posted Date: 2012-01-23

Last Posted Date: 2014-05-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1

Registration Number: NCT01515085

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Remote Ischemic Preconditioning in Neurological Death Organ Donors

Not Applicable

Completed

Conditions: Organ Transplantation

Interventions: Other: RIPC (Remote Ischemic Preconditioning)

First Posted Date: 2012-01-23

Last Posted Date: 2018-12-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 321

Registration Number: NCT01515072

Locations: 🇺🇸
Rutgers, The State University of New Jersey, Newark, New Jersey, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Transfusion Requirements During Spinal Surgery for Severe Scoliosis

Completed

Conditions: Scoliosis

First Posted Date: 2011-12-12

Last Posted Date: 2013-11-13

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 50

Registration Number: NCT01490164

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children

Phase 1

Completed

Conditions: Congenital Nasolacrimal Duct Obstruction

Interventions: Drug: Besivance Treatment Group
Drug: Polytrim Treatment Group

First Posted Date: 2011-09-09

Last Posted Date: 2016-07-14

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 24

Registration Number: NCT01431170

Locations: 🇺🇸
Institute of Ophthalmology and Visual Science, RUTGERS-New Jersey Medical School, Newark, New Jersey, United States

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Phase 2

Completed

Conditions: Papillary Ductal Breast Carcinoma
Stage IIIB Breast Cancer
Inflammatory Breast Cancer
Invasive Ductal Breast Carcinoma
Mucinous Ductal Breast Carcinoma
Invasive Lobular Breast Carcinoma
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIC Breast Cancer
Tubular Ductal Breast Carcinoma

Interventions: Radiation: External beam radiation therapy

First Posted Date: 2011-08-16

Last Posted Date: 2023-04-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 69

Registration Number: NCT01417286

Locations: 🇺🇸
Huntsman Cancer Hospital, Salt Lake City, Utah, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor - Protocol Specific
Breast Cancer - Female

Interventions: Drug: Pazopanib
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2011-08-02

Last Posted Date: 2022-09-28

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 34

Registration Number: NCT01407562

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy